What's breaking now, across thousands of outlets.
The 10th century treatment called Bald’s eyesalve attacks microbes in multiple ways. Molecule mixtures from it may inspire modern medicine.
We haven't written up this one. Science News has the full story — the link below goes straight to it.
New federal guidance urges employers to stock opioid reversal medication and train workers to use it, even as fentanyl detection declines.
The deal would yield a roughly $12.5 billion, multi-state integrated nonprofit with 22 hospitals and a 1.6 million-member insurance business.
The deal, which hands Novo a challenger to Lilly’s market-leading Zepbound, comes as the Danish drugmaker looks to calm investor fears about its future.
Attention-deficit/hyperactivity disorder (ADHD) is often discussed in terms of visible traits: fidgeting, distractibility, forgetfulness or restlessness. But those are just the traits we can see.
Researcher Tinne Laurberg told Newsweek that the gap has become "more pronounced in recent years."
A recent psychology experiment shows that taking a few minutes to watch hopeful, goal-oriented YouTube videos can temporarily reduce feelings of depression and boost personal motivation.
